论文部分内容阅读
近年来,代谢手术因其对肥胖型T2DM具有较显著、持久的控糖、减重和缓解其他代谢异常和伴发疾病的疗效而备受关注。以往的临床实践和指南关注的焦点多集中于手术适应证,尤其是BMI切点上。近年来指南的BMI切点呈下降趋势,BMI分界值趋于模糊,这得益于增量的临床证据使临床工作者对代谢手术治疗意义的认识已不再局限于对肥胖症和糖尿病本身的改善,而更注重对患者远期多重代谢及心血管危险因素的综合防治和全面获益的诉求。
In recent years, metabolic surgery has attracted much attention due to its obvious and long-lasting effect on controlling obesity T2DM, reducing weight and relieving other metabolic disorders and concomitant diseases. Past clinical practice and guidelines focus more on surgical indications, especially in the BMI cut point. In recent years, the guidelines for the BMI cut point showed a downward trend, BMI boundaries tend to be fuzzy, which benefits from incremental clinical evidence so that clinicians understanding of the significance of metabolic surgery is no longer confined to the obesity and diabetes itself Improve, and pay more attention to the long-term patients with multiple metabolic and cardiovascular risk factors for the comprehensive prevention and treatment of the overall demand for benefits.